Cholesterol news

All news on Cholesterol: plants, production capacities, investments and involved companies.

25 May 2026

Lilly's VERVE-102 single infusion durably lowers PCSK9 up to 88% and LDL-C up to 62%

Phase 1b Heart-2: single IV base-editing dose gave dose-dependent, durable PCSK9/LDL-C reductions up to 18 months in HeFH/premature CAD; well tolerated; FDA Fast Track; Phase 2 planned.
25 March 2026

Toray develops size-controlled PMMA porous fibers to selectively remove pathogenic proteins

PMMA porous fibers with controllable pores (several nm to ~1,000 nm) selectively capture high-MW pathogenic substances (autoantibodies, lipoproteins, exosomes), enabling blood purification and biopharma

Who will be producing Cholesterol in the future?

Find out with chemXplore Alpha

Learn more